Evaluation of ProLife 10 FORTE on Gut Microbiota Composition in UC Patients

This clinical trial aims to learn if the probiotic Prolife 10 Forte could improve the Gut Microbiota composition of Ulcerative colitis patients during the remission phase. The main questions it seeks to answer are: * Does Prolife 10 Forte improve the microbiota composition in patients with Ulcerative colitis? * Is it possible to highlight the variation in microbial pathways? * What clinical parameters vary and are associated with changes in the gut microbiota? Researchers will compare Prolife 10 Forte to a placebo (a look-alike substance containing no drug) to see if the probiotics improve microbiota. Participants will: * Take 1 vial/day of Prolife 10 Forte /Placebo for 60 days. * Visit the clinic two times for checkups, Questionaire and tests

NCT Number	NCT06642883
Lead Sponsor	University of Padova
Conditions	Ulcerative Colitis in Remission
Enrollment	70 participants
Start Date	2024-05-15
Primary Completion	2025-12-31 (estimated)
Study Completion	2026-06-15 (estimated)
Updated on ClinicalTrials.gov	2024-10-15